What is PRLD's dilution risk score?

PRLD has a latest available DilutionScore record of 43/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PRLD, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PRLD?

DilutionWatch tracks 25 SEC filing types for PRLD including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PRLD shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PRLD, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PRLD tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PRLD. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PRLD Dilution Risk Score: 43/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

27

💰 Cash Runway

40

📊 Float Risk

65

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 13%

💰 Capital Raise model 18%

• Active ATM program with $25M remaining capacity

🔄 Reverse Split model est. 15%

• 52-week low $0.75 has breached $1

🔔 Track PRLD — Get forecast alerts →

Market Data

Market Cap$312.21M

Shares Outstanding79.80M

Float22.96M

Cash$151.76M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 8.3% shares (2026Q1 vs prior)

57 institutional holders · 33.15M shares

#1 ORBIMED ADVISORS LLC 10.91M shares

#2 BAKER BROS. ADVISORS LP 10.12M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 2.46M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.67M

Days to Cover9.3

% of Float16.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31

3 FORM3 2026-04-15

3 FORM3 2026-03-19

8-K 8K EVENT 2026-03-12

424B5 ATM 2026-03-12

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PRLD Dilution Snapshot

Prelude Therapeutics Incorporated (PRLD) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $25.0M.
Recent SEC activity tracked for PRLD: 3 on 2026-04-15; 3 on 2026-03-19; 8-K on 2026-03-12.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.